GOLD Learning Speakers

USA

Jim Thigpen, PharmD, BCPS

  • Speaker Type: Pharmacology Lecture Pack 2017, Pain Management in the NICU Lecture Pack 2019
  • Country: USA
Biography:

Jim Thigpen, PharmD, BCPS, is Associate Professor, Department of Pharmacy Practice, Bill Gatton College of Pharmacy at East Tennessee State University.  He received his B.S. and PharmD degrees from the Medical University of South Carolina.  He completed a specialty residency in pediatrics and has served as a pediatric clinical pharmacist for the last 25 years.  He has a passion for educating student pharmacists, residents, and clinical team members in all aspects of pediatric pharmacotherapy.  He was awarded the Faculty Teaching Award in 2011 and the Outstanding Teacher Award by the classes of 2010, 2011 and 2015. His practice and research interests are broad and include neonatal abstinence syndrome, neonatal sepsis, medications in breastfeeding, among others. He has had the honor of speaking at the Academy of Neonatal Nursing Conference in 2012, 2014 and 2016.

CE Library Presentation(s) Available Online:
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Choosing wisely – Antibiotic Selection in the NICU
When faced with a potential neonatal infection, it is critical to choose the correct antibiotic(s) for the situation. Considering the environment of antibiotic resistance and some of the limitations for antibiotic use in this fragile population, selecting the right drug, dose, interval and monitoring parameters can be life and death decisions. This presentation will help the learner understand the complexities of this problem and provide them with the tools to provide state-of-the-art medical care.
Accreditation, Main Category
Presentations: 6  |  Hours / CE Credits: 6  |  Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details)  |  Categories: Neonates
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Clinical Pain Management in the Neonate
Managing pain and discomfort in the neonatal patient is complex in many ways. Immature metabolic processes can lead to unpredictable effects that may lead to either negative effects and/or unsuccessful control of pain. As we have learned more about these metabolic pathways and how these medications are utilized, more evidence now exists that determine when one medication may be preferred over another depending on the clinical situation. Looking into the future of drug dosing, we may soon be able to determine a neonate's pharmacogenomic profile in order to provide true personalized medicine. This presentation will help the learner understand the complexities of these challenges and provide them with the information and the tools to provide state-of-the-art medical care.
Accreditation, Main Category
Presentations: 5  |  Hours / CE Credits: 5  |  Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details)  |  Categories: